<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="letter"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Dermatol</journal-id><journal-id journal-id-type="publisher-id">derma</journal-id><journal-id journal-id-type="index">29</journal-id><journal-title>JMIR Dermatology</journal-title><abbrev-journal-title>JMIR Dermatol</abbrev-journal-title><issn pub-type="epub">2562-0959</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v8i1e66822</article-id><article-id pub-id-type="doi">10.2196/66822</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>Insights Into Skin-Lightening Practices of Hijra and Transgender Communities in India</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Palepu</surname><given-names>Sriram</given-names></name><degrees>BBA</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sindgi</surname><given-names>Vasudeva Murthy</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Srikrishnan</surname><given-names>Aylur Kailasom</given-names></name><degrees>BS</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kovarik</surname><given-names>Carrie</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><institution>Perelman School of Medicine</institution><addr-line>Philadelphia</addr-line><addr-line>PA</addr-line><country>United States</country></aff><aff id="aff2"><institution>Jayamukhi College of Pharmacy</institution><addr-line>Warangal</addr-line><country>India</country></aff><aff id="aff3"><institution>YR Gaitonde Centre for AIDS Research and Education</institution><addr-line>Chennai</addr-line><country>India</country></aff><aff id="aff4"><institution>Department of Dermatology, University of Pennsylvania</institution><addr-line>3600 Spruce St.</addr-line><addr-line>Philadelphia</addr-line><addr-line>PA</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Parker</surname><given-names>Eva</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Yeung</surname><given-names>Howa</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Lipoff</surname><given-names>Jules</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Carrie Kovarik, MD, Department of Dermatology, University of Pennsylvania, 3600 Spruce St., Philadelphia, PA, 19104-5162, United States, 1 215-662-2737; <email>carrie.kovarik@pennmedicine.upenn.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>5</month><year>2025</year></pub-date><volume>8</volume><elocation-id>e66822</elocation-id><history><date date-type="received"><day>24</day><month>09</month><year>2024</year></date><date date-type="rev-recd"><day>03</day><month>03</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>04</month><year>2025</year></date></history><copyright-statement>&#x00A9; Sriram Palepu, Vasudeva Murthy Sindgi, Aylur Kailasom Srikrishnan, Carrie Kovarik. Originally published in JMIR Dermatology (<ext-link ext-link-type="uri" xlink:href="http://derma.jmir.org">http://derma.jmir.org</ext-link>), 29.5.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://derma.jmir.org">http://derma.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://derma.jmir.org/2025/1/e66822"/><abstract><p>A large proportion of transgender women in Hyderabad, India (150/223, 67.3%) expressed interest in a wide range of topical, oral, and intravenous medications for skin lightening; however, despite government regulations and the potential health risks, persistent demand for skin lightening underscores the need for better patient education and safer skin care practices for this marginalized community.</p></abstract><kwd-group><kwd>skin lightening</kwd><kwd>India</kwd><kwd>medication misuse</kwd><kwd>insight</kwd><kwd>hijra</kwd><kwd>transgender women</kwd><kwd>treatment</kwd><kwd>patient education</kwd><kwd>skin care</kwd><kwd>community</kwd><kwd>fairness cream</kwd><kwd>marketing</kwd><kwd>ads</kwd><kwd>advertisement</kwd><kwd>cost</kwd><kwd>lightening cream</kwd><kwd>cross-sectional study</kwd><kwd>survey study</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The Government of India&#x2019;s recent amendments to the Drugs and Magic Remedies Act proposed increased penalties for marketing and advertising skin fairness creams [<xref ref-type="bibr" rid="ref1">1</xref>]. Yet, conventional Indian beauty standards still drive demand for skin-lightening products (SLPs) among women in India and transfeminine communities. Literature on skin-lightening practices among transgender people is limited. Transgender women undergoing estrogen therapy have an increased risk of melasma, which may be treated with skin-lightening agents like hydroquinone [<xref ref-type="bibr" rid="ref2">2</xref>]. An ethnographic study of Indonesia&#x2019;s transfeminine <italic>waria</italic> community found that members sought SLPs to feel more feminine and attract male attention [<xref ref-type="bibr" rid="ref3">3</xref>]. Similar motivations were documented among Thailand&#x2019;s transgender entertainers [<xref ref-type="bibr" rid="ref4">4</xref>].</p><p>The Health Needs and Aesthetic Preferences Assessment of the Hyderabad Trans Community is a large study evaluating the social and health history of transgender and <italic>hijra</italic> women in India (N=300). As part of that study, we evaluated the prevalence of interest in skin-lightening treatments, the products used, and the financial costs involved.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design</title><p>This cross-sectional survey study was conducted at Mitr Clinic (Hyderabad, India), using consecutive sampling. The survey was developed by the research team and administered in Hindi, Telugu, or English. The inclusion criteria were as follows: <italic>hijra</italic> and/or transgender women aged &#x2265;18 years, seeking female gender affirmation, and South Asian ancestry. Transgender men, individuals seeking male gender affirmation, and individuals aged &#x003C;18 years were excluded. Dollar amounts were estimated based on the March 19, 2023, exchange rate.</p></sec><sec id="s2-2"><title>Ethical Considerations</title><p>Because some community members have limited literacy, verbal consent was obtained before data collection. No protected health information was collected. Institutional review board (IRB) approvals were obtained from the University of Pennsylvania and YR Gaitonde Centre for AIDS Research and Education&#x2014;the clinic&#x2019;s overseeing nonprofit. Remuneration (&#x20B9;500 [US $5.84]) was provided to patients for their time and participation.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>An IRB addendum approved in December 2023 enabled 74.3% (223/300) of participants to respond to skin lightening&#x2013;related questions. More than two-thirds (150/223, 67.3%) of respondents expressed interest in skin lightening, of whom 43.3% (65/150) used SLPs. The overall prevalence of SLPs among respondents was 29.1% (65/223). Further, 1.3% (2/150) of respondents used SLPs previously but lost interest, and 3.1% (7/223) could not recollect or identify the products they used. Money spent on skin lightening varied from &#x20B9;25 (US $0.30) to &#x20B9;70,000 (US $843; median &#x20B9;570 [US $7], IQR &#x20B9;2225 [US $27]). Patients sometimes used multiple products (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Ingredients of self-reported products used for skin lightening.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Type of product used<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup></td><td align="left" valign="bottom">Active ingredients in products<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup></td></tr></thead><tbody><tr><td align="left" valign="top">Topical treatments (n=23)</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Hydroquinone + tretinoin + mometasone furoate (n=15)</p></list-item><list-item><p>Clobetasol + neomycin + miconazole nitrate (n=1)</p></list-item><list-item><p>Glycolic acid + arbutin + kojic acid (n=1)</p></list-item><list-item><p>Terbinafine + ornidazole + oflaxicin + clobetasol (n=2)</p></list-item><list-item><p>Betamethasone cream (n=3)</p></list-item><list-item><p>Sunscreen (n=1)</p></list-item></list></td></tr><tr><td align="left" valign="top">Oral medications (n=2)</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Levonorgestrel/ethinyloestradiol (n=1)</p></list-item><list-item><p>Biotin + multivitamin (n=1)</p></list-item></list></td></tr><tr><td align="left" valign="top">Intravenous medications (n=16)</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Glutathione (n=16)</p></list-item></list></td></tr><tr><td align="left" valign="top">Alternative (herbal/Ayurvedic/Unani; n=5)</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Combination of ingredients, including lycopene, botanical extracts (eg, mallow, cowslip, licorice, and aloe vera), and soy isoflavones</p></list-item></list></td></tr><tr><td align="left" valign="top">Marketed beauty creams (n=15)</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Combination of ingredients, including herbal ingredients, kojic acid, niacinamide, vitamin C, vitamin E, and sun protection factors (octocrylene, avobenzone, etc)</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>The n values in this column refer to the number of products reported.</p></fn><fn id="table1fn2"><p><sup>b</sup>The n values in this column refer to the number of products that contained the active ingredients listed in this column.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>Our study highlights the considerable interest in SLPs but marginally low prevalence of SLP use (likely due to financial barriers) among <italic>hijra</italic> and transgender women. Survey studies on cisgender populations in India indicate that SLPs have widespread prevalence (range 34%-60%) [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>]. Deeply rooted cultural norms associate lighter skin with economic prosperity and beauty, leading to widespread use even among South Asian immigrant communities [<xref ref-type="bibr" rid="ref7">7</xref>]. Although 67.3% of our respondents expressed interest in skin lightening, only 29.1% used SLPs&#x2014;a lower rate than in cisgender communities. Within the colorism context, transfeminine individuals may view skin lightening as an accessible method for facilitating gender affirmation and social acceptance, as observed in other Asian countries.</p><p>Transgender women often face stigma and discrimination in health care settings, preventing them from seeking care [<xref ref-type="bibr" rid="ref8">8</xref>]. Additionally, many transgender women in India engage in sex work, which acts a strong economic driver for investing in physical appearance (eg, undergoing skin treatments to achieve a desired aesthetic) [<xref ref-type="bibr" rid="ref8">8</xref>]. Although many respondents were interested in skin lightening, less than half used SLPs, which included herbal mixtures from local shops and intravenous glutathione injections.</p><p>A study on SLPs used in India reported topical medication misuse prior to seeing a dermatologist [<xref ref-type="bibr" rid="ref9">9</xref>]. The combination of hydroquinone, mometasone, and tretinoin cream is a common, over-the-counter melasma treatment in India [<xref ref-type="bibr" rid="ref9">9</xref>]. Glutathione injections, though popular and expensive, have questionable efficacy [<xref ref-type="bibr" rid="ref10">10</xref>]. Some alternative, traditional remedy&#x2013;based medications are often cheaper. Popular marketed beauty creams use ingredients like kojic acid, niacinamide, and arbutin, which have been studied for their effects on skin pigmentation and complexion [<xref ref-type="bibr" rid="ref11">11</xref>]. Chronic steroid use, while lightening some patients&#x2019; skin, may result in skin atrophy and other side effects [<xref ref-type="bibr" rid="ref12">12</xref>]. Antifungal creams may treat pigmentary changes resulting from infections like pityriasis versicolor but have no additional lightening effects. Only 1 respondent reported using sunscreen daily, beyond sun protection factors in beauty creams.</p><p>Almost half of our respondents use medications with skin-lightening properties&#x2014;mostly purchased over the counter. After the COVID-19 pandemic, the average <italic>hijra</italic> community member&#x2019;s earnings decreased from US $7 to US $13 per day to less than US $2 per day [<xref ref-type="bibr" rid="ref13">13</xref>]. Many members are of low socioeconomic status and have been reported to seek hormonal and surgical care from unqualified medical practitioners because allopathic treatments are costly [<xref ref-type="bibr" rid="ref14">14</xref>]. Despite the Indian government&#x2019;s regulatory efforts, interest in SLPs persists among transgender women [<xref ref-type="bibr" rid="ref1">1</xref>]. However, only a fraction can afford to regularly use skin-lightening treatments. Given the potential health and financial risks, patient education about safe skin care is crucial for transgender women to make informed health decisions.</p><p>This study had several limitations, which we hope to address in follow-up studies. Participants&#x2019; informal occupations (eg, begging and sex work) precluded an accurate income assessment. Furthermore, the ad hoc survey lacked prior psychometric validation; this may have affected the accuracy of estimates regarding SLP use. Lastly, data on individual product costs and usage durations were not collected, limiting insights into the costs of long-term use.</p></sec></body><back><ack><p>We thank the Fulbright Program and the United States-India Educational Foundation (USIEF) for financially supporting this project.</p></ack><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">IRB</term><def><p>institutional review board</p></def></def-item><def-item><term id="abb2">SLP</term><def><p>skin-lightening product</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raj</surname><given-names>S</given-names> </name><name name-style="western"><surname>Sampat</surname><given-names>B</given-names> </name><name name-style="western"><surname>Kajla</surname><given-names>T</given-names> </name><name name-style="western"><surname>Singh</surname><given-names>H</given-names> </name></person-group><article-title>Dark side of skin&#x2010;lightening products: social responsibility of advertisers</article-title><source>Int Soc Sci J</source><year>2022</year><month>09</month><volume>72</volume><issue>245</issue><fpage>525</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1111/issj.12339</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeung</surname><given-names>H</given-names> </name><name name-style="western"><surname>Kahn</surname><given-names>B</given-names> </name><name name-style="western"><surname>Ly</surname><given-names>BC</given-names> </name><name name-style="western"><surname>Tangpricha</surname><given-names>V</given-names> </name></person-group><article-title>Dermatologic conditions in transgender populations</article-title><source>Endocrinol Metab Clin North Am</source><year>2019</year><month>06</month><volume>48</volume><issue>2</issue><fpage>429</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.ecl.2019.01.005</pub-id><pub-id pub-id-type="medline">31027550</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Idrus</surname><given-names>NI</given-names> </name><name name-style="western"><surname>Hymans</surname><given-names>TD</given-names> </name></person-group><article-title>Balancing benefits and harm: chemical use and bodily transformation among Indonesia&#x2019;s transgender waria</article-title><source>Int J Drug Policy</source><year>2014</year><month>07</month><volume>25</volume><issue>4</issue><fpage>789</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2014.06.012</pub-id><pub-id pub-id-type="medline">25091633</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farber</surname><given-names>R</given-names> </name></person-group><article-title>Transitioning Thailand: techno&#x2010;professionalism and nation&#x2010;building in the transgender entertainment industry</article-title><source>Gend Work Organ</source><year>2024</year><month>11</month><volume>31</volume><issue>6</issue><fpage>2489</fpage><lpage>2510</lpage><pub-id pub-id-type="doi">10.1111/gwao.13104</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacob</surname><given-names>SM</given-names> </name><name name-style="western"><surname>Thillaikarasi</surname><given-names>A</given-names> </name></person-group><article-title>Awareness on skin lightening practice and their side effects among nursing staff in a tertiary care centre</article-title><source>Indian J Dermatol</source><year>2023</year><volume>68</volume><issue>3</issue><fpage>356</fpage><pub-id pub-id-type="doi">10.4103/ijd.ijd_1010_22</pub-id><pub-id pub-id-type="medline">37529465</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>C</given-names> </name><name name-style="western"><surname>Wong</surname><given-names>S</given-names> </name><name name-style="western"><surname>Tang</surname><given-names>H</given-names> </name><name name-style="western"><surname>Minocha</surname><given-names>R</given-names> </name><name name-style="western"><surname>Singh</surname><given-names>R</given-names> </name><name name-style="western"><surname>Grills</surname><given-names>N</given-names> </name></person-group><article-title>Use of skin-lightening products among outpatient attendees in a North Indian hospital</article-title><source>Indian J Public Health</source><year>2017</year><volume>61</volume><issue>2</issue><fpage>137</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.4103/ijph.IJPH_318_15</pub-id><pub-id pub-id-type="medline">28721966</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banala</surname><given-names>M</given-names> </name><name name-style="western"><surname>Mamidipaka</surname><given-names>A</given-names> </name><name name-style="western"><surname>Ogunleye</surname><given-names>T</given-names> </name></person-group><article-title>Skin-lightening product use among South Asian Americans: cross-sectional survey study</article-title><source>JMIR Dermatol</source><year>2023</year><month>11</month><day>2</day><volume>6</volume><fpage>e49068</fpage><pub-id pub-id-type="doi">10.2196/49068</pub-id><pub-id pub-id-type="medline">37917151</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Nuttbrock</surname><given-names>L</given-names> </name></person-group><source>Transgender Sex Work and Society</source><year>2019</year><publisher-name>Harrington Park Press</publisher-name><pub-id pub-id-type="other">9781939594402</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godse</surname><given-names>KV</given-names> </name><name name-style="western"><surname>Zawar</surname><given-names>V</given-names> </name></person-group><article-title>Mometasone menace in melasma</article-title><source>Indian J Dermatol</source><year>2012</year><month>07</month><volume>57</volume><issue>4</issue><fpage>324</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.4103/0019-5154.97686</pub-id><pub-id pub-id-type="medline">22837578</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonthalia</surname><given-names>S</given-names> </name><name name-style="western"><surname>Jha</surname><given-names>AK</given-names> </name><name name-style="western"><surname>Lallas</surname><given-names>A</given-names> </name><name name-style="western"><surname>Jain</surname><given-names>G</given-names> </name><name name-style="western"><surname>Jakhar</surname><given-names>D</given-names> </name></person-group><article-title>Glutathione for skin lightening: a regnant myth or evidence-based verity?</article-title><source>Dermatol Pract Concept</source><year>2018</year><month>01</month><day>31</day><volume>8</volume><issue>1</issue><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.5826/dpc.0801a04</pub-id><pub-id pub-id-type="medline">29445569</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>YH</given-names> </name><name name-style="western"><surname>Avonto</surname><given-names>C</given-names> </name><name name-style="western"><surname>Avula</surname><given-names>B</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>M</given-names> </name><name name-style="western"><surname>Rua</surname><given-names>D</given-names> </name><name name-style="western"><surname>Khan</surname><given-names>IA</given-names> </name></person-group><article-title>Quantitative determination of &#x03B1;-arbutin, &#x03B2;-arbutin, kojic acid, nicotinamide, hydroquinone, resorcinol, 4-methoxyphenol, 4-ethoxyphenol, and ascorbic acid from skin whitening products by HPLC-UV</article-title><source>J AOAC Int</source><year>2015</year><volume>98</volume><issue>1</issue><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.5740/jaoacint.14-123</pub-id><pub-id pub-id-type="medline">25857872</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>A</given-names> </name><name name-style="western"><surname>Roga</surname><given-names>G</given-names> </name></person-group><article-title>Topical steroid-damaged skin</article-title><source>Indian J Dermatol</source><year>2014</year><month>09</month><volume>59</volume><issue>5</issue><fpage>456</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.4103/0019-5154.139872</pub-id><pub-id pub-id-type="medline">25284849</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chakrapani</surname><given-names>V</given-names> </name><name name-style="western"><surname>Newman</surname><given-names>PA</given-names> </name><name name-style="western"><surname>Sebastian</surname><given-names>A</given-names> </name><name name-style="western"><surname>Rawat</surname><given-names>S</given-names> </name><name name-style="western"><surname>Shunmugam</surname><given-names>M</given-names> </name><name name-style="western"><surname>Sellamuthu</surname><given-names>P</given-names> </name></person-group><article-title>The impact of COVID-19 on economic well-being and health outcomes among transgender women in India</article-title><source>Transgend Health</source><year>2022</year><month>10</month><day>1</day><volume>7</volume><issue>5</issue><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1089/trgh.2020.0131</pub-id><pub-id pub-id-type="medline">36406642</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Aher</surname><given-names>A</given-names> </name><name name-style="western"><surname>Shaikh</surname><given-names>S</given-names> </name><name name-style="western"><surname>Mehta</surname><given-names>S</given-names> </name><name name-style="western"><surname>Robertson</surname><given-names>J</given-names> </name><name name-style="western"><surname>Chakrapani</surname><given-names>V</given-names> </name></person-group><article-title>Gender transition services for hijras and other male-to-female transgender people in India: availability and barriers to access and use</article-title><source>Int J Transgend</source><year>2014</year><month>01</month><day>2</day><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1080/15532739.2014.890559</pub-id></nlm-citation></ref></ref-list></back></article>